WAVE Life Sciences Q3 EPS $(0.30) Beats $(0.33) Estimate, Sales $13.158M Beat $4.317M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 6.25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $13.158 million which beat the analyst consensus estimate of $4.317 million by 204.81 percent. This is a 72.95 percent increase over sales of $7.608 million the same period last year.